Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Lockwood

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Immunology|July 15, 1999
Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI)A A Brownlee, C M Lockwood
Experientia|April 15, 1970
Effects of phenethyl alcohol on influenza virus growth and macromolecular synthesis in chick embryo cellsB W Mahy, C M Lockwood
QJM : Monthly Journal of the Association of Physicians|November 1, 1995
Antigen specificity in hydralazine associated ANCA positive systemic vasculitisA K Short, C M Lockwood
Postgraduate Medical Journal|September 1, 1993
Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitisK N Lai, C M Lockwood
Lancet (London, England)|February 17, 1990
Pathogenesis of acute Kawasaki diseaseD R Jayne, C M Lockwood
Clinical and Experimental Immunology|September 1, 1991
The effect of anti-neutrophil cytoplasm autoantibodies on the signal transduction in human neutrophilsK N Lai, C M Lockwood
Transactions of the Association of American Physicians|January 1, 1991
High-dose pooled immunoglobulin in the therapy of systemic vasculitisD R Jayne, C M Lockwood
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 1, 1996
ANCA defines the clinical disease manifestations of vasculitisM H Zhao, C M Lockwood
British Journal of Rheumatology|November 1, 1996
Intravenous immunoglobulin as sole therapy for systemic vasculitisD R Jayne, C M Lockwood
Progress in Clinical and Biological Research|January 1, 1982
Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritisC D Pusey, C M Lockwood
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Immunology|July 15, 1999
Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI)A A Brownlee, C M Lockwood
Experientia|April 15, 1970
Effects of phenethyl alcohol on influenza virus growth and macromolecular synthesis in chick embryo cellsB W Mahy, C M Lockwood
QJM : Monthly Journal of the Association of Physicians|November 1, 1995
Antigen specificity in hydralazine associated ANCA positive systemic vasculitisA K Short, C M Lockwood
Postgraduate Medical Journal|September 1, 1993
Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitisK N Lai, C M Lockwood
Lancet (London, England)|February 17, 1990
Pathogenesis of acute Kawasaki diseaseD R Jayne, C M Lockwood
Clinical and Experimental Immunology|September 1, 1991
The effect of anti-neutrophil cytoplasm autoantibodies on the signal transduction in human neutrophilsK N Lai, C M Lockwood
Transactions of the Association of American Physicians|January 1, 1991
High-dose pooled immunoglobulin in the therapy of systemic vasculitisD R Jayne, C M Lockwood
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 1, 1996
ANCA defines the clinical disease manifestations of vasculitisM H Zhao, C M Lockwood
British Journal of Rheumatology|November 1, 1996
Intravenous immunoglobulin as sole therapy for systemic vasculitisD R Jayne, C M Lockwood
Progress in Clinical and Biological Research|January 1, 1982
Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritisC D Pusey, C M Lockwood
Pageof 18